Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02751710Not ApplicableCompleted
Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer
Stage IIb Breast Cancer (T3N0)Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4)
PrincipalinvestigatorStart date: 2016-12-06

Research Network

Collaboration Network

29 collaborators·37 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Juravinski Hospital and Cancer Centre

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02751710Not ApplicablePrincipalInvestigator

Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer

Stage IIb Breast Cancer (T3N0)Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4)
Completed

All 1 trials loaded